The use of in-shoe foot orthoses in the short-term treatment of anterior knee pai

Not Applicable

Completed

• Conditions: Anterior knee pain; Musculoskeletal - Other muscular and skeletal disorders

• Registration Number: ACTRN12611000492954
• Lead Sponsor: niversity of Queensland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-05-11
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Patients complain of anterior or retropatella pain of greater than 6-weeks duration aggravated by 2 of the following activities: running, stair or hill climbing, hopping, jumping, squatting, kneeling or sitting for long periods of time. Pain on palpation of the patella facet or on deep squat.

Exclusion Criteria

(1) concomitant pain or injury in the hip, pelvis or lumbar spine;
(2) damage to any knee structures or indications of patella tendinosis;
(3) chronic patella instability
(4) knee effusion;
(5) any foot conditions that would preclude the use of orthoses;
(6) the use of physiotherapy treatment for knee pain or foot orthoses in the previous 3 years; or
(7) previous lower limb surgery.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patient perceived improvement on a 6-point Global Improvement scale: completely recovered, much improved, improved, no change, worse and much worse. Completely recovered and much improved are considered successful treatment[6 weeks];Neuromotor changes of gluteus medius, biceps femoris, vastus lateralis, vastus medialis obliquus, rectus femoris, tibialis anterior, soleus and medial gastrocnemius. Measured by comparing electromyography signals recorded while jogging wearing the shoe with those recorded when jogging wearing the orthoses.[Baseline and at 6-weeks after baseline]

Secondary Outcome Measures

Name	Time	Method
100 mm visual analogue scale for usual pain over the preceeding week. Changes > 20mm considered clinically meaningful[Baseline and 6-weeks after baseline];100 mm visual analogue scale for worst pain over the preceeding week. Changes > 20mm considered clinically meaningful[Baseline and 6-weeks after baseline];Kujala Patellofemoral Score > 10 points change from baseline to follow-up[Baseline and 6-weeks after baseline];Patient Specific Functional Scale >2 points change is considered clinically meaningful[Baseline and 6-weeks after baseline]